Sign in
4

Changes in Ownership

Mirum Pharmaceuticals, Inc. Filed Acc 0001614740-26-000003

CHIEF EXECUTIVE OFFICER sold 6,831 shares at $96.19 ($657,088)

  • CHIEF EXECUTIVE OFFICER acquired 12,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Peetz Christopher · CHIEF EXECUTIVE OFFICER

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-01-23 Exercise or conversion : show line 1 in the form +12,500 176,233 D
2026-01-26 Sale : show line 2 in the form −6,831 $96.19 $657,088 169,402 D
Open-market sales · 6,831 sh · avg $96.19 · $657,088

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-01-23 Exercise or conversion : show line 3 in the form Restricted Stock Units −12,500 12,500 D
Loading xslF345X05/form4-01272026_040103.xml…